150.18 0.00 (0.00%)
After hours: 4:32PM EST
|Bid||150.27 x 1000|
|Ask||150.28 x 2900|
|Day's Range||149.39 - 150.57|
|52 Week Range||90.64 - 151.46|
|Beta (3Y Monthly)||0.41|
|PE Ratio (TTM)||51.79|
|Earnings Date||Jan 22, 2020 - Jan 27, 2020|
|Forward Dividend & Yield||1.56 (1.04%)|
|1y Target Est||138.00|
Myriad Genetics (MYGN) posts breakthrough results on Prequel Prenatal Screen methodology, proving its superiority over traditional methods.
Within NuVasive's (NUVA) U.S. Spinal Hardware business, a strong uptick in case volume and tangible growth in the XLIF and ALIF franchises are major upsides.
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Haemonetics (HAE) expands the transfusion management portfolio with SafeTrace Tx, the latest in its transfusion management software product line.
BioSig Technologies (BSGM) signs agreement with Mayo Foundation for improving arrhythmia treatment along with covering therapies for autonomic nervous system disease.